TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Microba Life Sciences Limited ( (AU:MAP) ) has shared an update.
Microba Life Sciences Limited has released its Corporate Governance Statement, highlighting its commitment to high standards of corporate governance. The company has adopted a formal Board Charter outlining roles and responsibilities, and has established a Nomination and Remuneration Committee to ensure effective governance practices. This announcement underscores Microba’s dedication to transparency and accountability, which may strengthen its position in the life sciences industry and provide assurance to stakeholders.
The most recent analyst rating on (AU:MAP) stock is a Buy with a A$0.19 price target. To see the full list of analyst forecasts on Microba Life Sciences Limited stock, see the AU:MAP Stock Forecast page.
More about Microba Life Sciences Limited
Microba Life Sciences Limited operates in the life sciences industry, focusing on microbiome analysis and related services. The company is committed to implementing high standards of corporate governance, guided by the ASX Corporate Governance Council’s Principles and Recommendations.
Average Trading Volume: 462,185
Technical Sentiment Signal: Sell
Current Market Cap: A$58.46M
For detailed information about MAP stock, go to TipRanks’ Stock Analysis page.